[1] BENDELAC A, SAVAGE P B, TEYTON L. The biology of NKT cells[J]. Annu Rev Immunol, 2007,25(1):297-336. [2] BENLAGHA K, WEI D G, VEIGA J, et al. Characterization of the early stages of thymic NKT cell development[J]. J Exp Med, 2005,202(4):485-492. [3] SCHMIDT S, TRAMSEN L, RAIS B, et al. Natural killer cells as a therapeutic tool for infectious diseases-current status and future perspectives[J]. Oncotarget, 2018, 9(29):20891-20907. [4] NAIR S, DHODAPKAR M V. Natural killer T cells in cancer immunotherapy[J]. Front Immunol, 2017,8:1178. [5] VAN KAER L, WU L. Therapeutic potential of invariant natural killer T cells in autoimmunity[J]. Front Immunol, 2018,9:519. [6] STENGEL K R, ZHAO Y, KLUS N J, et al. Histone deacetylase 3 is required for efficient T cell development[J].Mol Cell Biol, 2015,35(22):3854-3865. [7] STENGEL K R, BARNETT K R, WANG J, et al. Deacetylase activity of histone deacetylase 3 is required for productive VDJ recombination and B-cell development[J]. Proc Natl Acad Sci U S A, 2017,114(32):8608-8613. [8] CHEN X, BAROZZI I, TERMANINI A, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages[J]. Proc Natl Acad Sci U S A, 2012,109(42):E2865-E2874. [9] YASHIRO T, KUBO M, OGAWA H, et al. PU.1 suppresses Th2 cytokine expression via silencing of GATA3 transcription in dendritic cells[J]. PLoS One, 2015,10(9):e0137699. [10] 王姗, 田枫, 千晔, 等. 组蛋白去乙酰化酶3通过抑制AICD维持T细胞自稳[J]. 生物化学与生物物理进展,2018,45(1):79-90. [11] ELIZALDE C, FERNÁNDEZ-RUEDA J, SALCEDO J M, et al. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells[J]. Stem Cells Dev, 2012,21(14):2581-2591. [12] WELLS C E, BHASKARA S, STENGEL K R, et al. Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma[J]. PLoS One, 2013,8(7):e68915. [13] THAPA P, ROMERO AROCHA S, CHUNG J Y,et al. Histone deacetylase 3 is required for iNKT cell development[J]. Sci Rep, 2017,7(1):5784. [14] GAPIN L, MATSUDA J L, SURH C D, et al. NKT cells derive from double-positive thymocytes that are positively selected by CD1d[J].Nat Immunol, 2001,2(10):971-978. [15] VILLANUEVA J E, MALLE E K, GARDAM S, et al.TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15[J]. Eur J Immunol,2015,45(6):1820-1831. [16] ZHU L L, XIE X P, ZHANG L Y, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival[J]. Nat Commun, 2018,9(1):2812. [17] THAPA P, DAS J, MCWILLIAMS D, et al. The transcriptional repressor NKAP is required for the development of iNKT cells[J]. Nat Commun, 2013,4:1582. [18] EGAWA T, EBERL G, TANIUCHI I, et al.Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors[J]. Immunity, 2005, 22(6):705-716. [19] DURST K L, LUTTERBACH B, KUMMALUE T, et al. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain[J].Mol Cell Biol, 2003,23(2):607-619. [20] MATSUDA J L, NAIDENKO O V, GAPIN L,et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers[J]. J Exp Med, 2000,192(5):741-754. [21] BENLAGHA K, KYIN T, BEAVIS A,et al. A thymic precursor to the NK T cell lineage[J].Science, 2002,296(5567):553-555. |